Advertisement
Loading...

Cardiol Therapeutics Inc.

CRDL•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.32
$-0.05(-3.65%)
U.S. Market opens in 28h 24m

Cardiol Therapeutics Inc. (CRDL) Stock Overview

Explore Cardiol Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap147.4M
P/E Ratio-5.51
EPS (TTM)$-0.29
ROE-2.29%
Fundamental Analysis

AI Price Forecasts

1 Month$0.75
3 Months$1.59
1 Year Target$0.34

CRDL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cardiol Therapeutics Inc. (CRDL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.51 and a market capitalization of 147.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.65%
5-Day Change
-0.75%
1-Month Change
-7.69%
3-Month Change
26.92%
6-Month Change
29.41%
Year-to-Date (YTD) Change
38.39%
1-Year Change
15.79%
3-Year Change
140.00%
5-Year Change
-48.43%
All-Time (Max) Change
-64.72%

Contact Information

https://www.cardiolrx.com
289 910 0850
2265 Upper Middle Road East, Oakville, ON, L6H 0G5

Company Facts

18 Employees
IPO DateJan 15, 2019
CountryCA
Actively Trading

Frequently Asked Questions